KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Moderna (MRNA) EBT Margin (2017 - 2025)

Moderna (MRNA) has disclosed EBT Margin for 9 consecutive years, with 117.85% as the latest value for Q4 2025.

  • Quarterly EBT Margin rose 472.0% to 117.85% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 142.39% through Dec 2025, down 2864.0% year-over-year, with the annual reading at 142.39% for FY2025, 3092.0% down from the prior year.
  • EBT Margin for Q4 2025 was 117.85% at Moderna, down from 18.41% in the prior quarter.
  • The five-year high for EBT Margin was 75.02% in Q4 2021, with the low at 892.59% in Q1 2025.
  • Average EBT Margin over 5 years is 165.37%, with a median of 7.63% recorded in 2024.
  • The sharpest move saw EBT Margin surged 161505bps in 2021, then crashed -68122bps in 2024.
  • Over 5 years, EBT Margin stood at 75.02% in 2021, then tumbled by -57bps to 32.55% in 2022, then plummeted by -92bps to 2.49% in 2023, then tumbled by -5022bps to 122.57% in 2024, then rose by 4bps to 117.85% in 2025.
  • According to Business Quant data, EBT Margin over the past three periods came in at 117.85%, 18.41%, and 576.06% for Q4 2025, Q3 2025, and Q2 2025 respectively.